We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+33.48%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$611M
AUM Growth
+$11.7M
(+2%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-15.04%
Top 10 Holdings %
Top 10 Hldgs %
4.77%
Holding
1,794
New
573
Increased
263
Reduced
313
Closed
643
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Best Buy
BBY
|
+$2.79M |
| 2 |
Bath & Body Works
BBWI
|
+$2.78M |
| 3 |
Advanced Micro Devices
AMD
|
+$2.7M |
| 4 |
NVIDIA
NVDA
|
+$2.4M |
| 5 |
ExxonMobil
XOM
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$10.9M |
| 2 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$7.99M |
| 3 |
ORPH
Orphazyme A/S
ORPH
|
+$5.06M |
| 4 |
BridgeBio Pharma
BBIO
|
+$3.35M |
| 5 |
BPY
Brookfield Property Partners L.P. Limited Partnership Units
BPY
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.42% |
| 2 | Technology | 16.03% |
| 3 | Healthcare | 14.17% |
| 4 | Industrials | 13.91% |
| 5 | Financials | 11.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Prestige Consumer Healthcare
PBH
$2.6B
| $220K | 0.04% |
+6,321
| New | +$224K |
|
927
Alcoa
AA
$13.2B
| $219K | 0.04% |
9,500
-17,190
| -64% | -$299K |
|
|
CMRC
928
Commerce.com Inc Series 1
CMRC
$184M
| $219K | 0.04% |
+3,418
| New | +$273K |
|
|
BRSL
929
Brightstar Lottery PLC
BRSL
$2.03B
| $219K | 0.04% |
+12,948
| New | +$158K |
|
|
CSGS
930
DELISTED
CSG Systems International
CSGS
| $218K | 0.04% |
+4,834
| New | +$206K |
|
931
First Trust Technology AlphaDEX Fund
FXL
$2.79B
| $218K | 0.04% |
+1,953
| New | +$198K |
|
932
Datadog
DDOG
$84B
| $217K | 0.04% |
2,208
+222
| +11% | +$22.2K |
|
933
Fulgent Genetics
FLGT
$527M
| $217K | 0.04% |
+4,168
| New | +$174K |
|
934
Goldman Sachs
GS
$303B
| $217K | 0.04% |
+824
| New | +$183K |
|
|
GLOP
935
DELISTED
GASLOG PARTNERS LP
GLOP
| $217K | 0.04% |
+79,764
| New | +$243K |
|
|
HTGM
936
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $217K | 0.04% |
3,768
-2,931
| -44% | -$171K |
|
937
Marker Therapeutics
MRKR
$18.7M
| $216K | 0.04% |
14,863
+6,072
| +69% | +$94.3K |
|
938
NextEra Energy
NEE
$177B
| $216K | 0.04% |
2,800
-2,020
| -42% | -$151K |
|
939
Invesco QQQ Trust
QQQ
$481B
| $216K | 0.04% |
+687
| New | +$202K |
|
|
NPKI
940
NPK International
NPKI
$1.14B
| $216K | 0.04% |
+112,632
| New | +$151K |
|
941
Toronto Dominion Bank
TD
$200B
| $215K | 0.04% |
+3,805
| New | +$193K |
|
|
JNCE
942
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $215K | 0.04% |
+30,696
| New | +$239K |
|
|
ARI
943
Apollo Commercial Real Estate
ARI
$885M
| $214K | 0.04% |
19,191
-7,443
| -28% | -$76.3K |
|
944
Carrier Global
CARR
$52.8B
| $214K | 0.04% |
+5,669
| New | +$205K |
|
945
First Solar
FSLR
$26.9B
| $214K | 0.04% |
+2,164
| New | +$188K |
|
946
Powell Industries
POWL
$7.71B
| $214K | 0.04% |
21,813
-25,008
| -53% | -$223K |
|
947
Trex
TREX
$5.01B
| $214K | 0.04% |
+2,561
| New | +$196K |
|
948
Costamare
CMRE
$1.77B
| $213K | 0.03% |
25,726
-140,118
| -84% | -$976K |
|
949
First Financial Bancorp
FFBC
$3.53B
| $213K | 0.03% |
12,170
-11,287
| -48% | -$177K |
|
|
MODV
950
DELISTED
ModivCare
MODV
| $213K | 0.03% |
+1,539
| New | +$191K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, GSA Capital Partners held 1,794 positions worth $611M, up 2% from $600M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.
GSA Capital Partners withdrew a net $91.9M in Q4 2020, closing 643 positions and reducing 313 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $10.9M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.
Against the trend, GSA Capital Partners opened a new position in Best Buy worth $2.49M.
- GSA Capital Partners's largest Q4 2020 buy was Best Buy: 24,945 shares worth $2.49M.
- GSA Capital Partners added most to Advanced Micro Devices in Q4 2020, an estimated $2.7M increase.
- GSA Capital Partners's biggest Q4 2020 reduction was BridgeBio Pharma, cutting an estimated $3.35M.
- GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $10.9M.
- GSA Capital Partners's ten largest holdings make up 4.8% of its $611M portfolio in Q4 2020.
- GSA Capital Partners opened 573 new positions and closed 643 in Q4 2020.
- GSA Capital Partners's portfolio value rose 2% quarter-over-quarter to $611M.
Based on GSA Capital Partners's 13F filing for Q4 2020, filed 3 Feb 2021.